Efficacy of tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infected patients.

被引:0
|
作者
Benhamou, Y
Piketty, C
Katlama, C
Rozembaum, W
Neau, D
Lafeuillade, A
Rey, D
Yazdanpanah, Y
Trimoulet, P
Fleury, H
机构
[1] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
[2] Hop Georges Pompidou, Paris, France
[3] Hop Tenon, F-75970 Paris, France
[4] Hop Pellegrin, F-33076 Bordeaux, France
[5] Hop Chalucet, Toulon, France
[6] Hop Tourcoing, Strasbourg, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1155
引用
收藏
页码:712A / 713A
页数:2
相关论文
共 50 条
  • [1] Hepatitis B virus (HBV) mutations associated with lamivudine resistance in human immunodeficiency virus (HIV)-infected patients.
    Thibault, V
    Benhamou, Y
    Seguret, C
    Bocher, M
    Katlama, C
    Bricaire, F
    Opolon, P
    Poynard, T
    Huraux, JM
    HEPATOLOGY, 1998, 28 (04) : 485A - 485A
  • [2] Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppression
    Wong, Tammy C.
    Lan, Audrey
    Kiser, Jennifer J.
    Anderson, Peter L.
    Patel, Keyur
    Tillman, Hans
    Naggie, Susanna
    HEPATOLOGY, 2016, 64 (03) : 999 - 1000
  • [3] Anti-hepatitis B virus efficacy of tendovir disoproxil fumarate in HIV-infected patients
    Benhamou, Y
    Fleury, H
    Trimoulet, P
    Pellegrin, I
    Urbinelli, R
    Katlama, C
    Rozenbaum, W
    Le Teuff, G
    Trylesinski, A
    Piketty, C
    HEPATOLOGY, 2006, 43 (03) : 548 - 555
  • [4] Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
    Benhamou, Y
    Tubiana, R
    Thibault, V
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (02): : 177 - 178
  • [5] Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate
    Lacombe, K
    Gozlan, J
    Boelle, PY
    Serfaty, L
    Zoulim, F
    Valleron, AJ
    Girard, PM
    AIDS, 2005, 19 (09) : 907 - 915
  • [6] Novel Quantification of Tenofovir Disoproxil Fumarate Adherence in Human Immunodeficiency Virus/Hepatitis B Coinfected Patients With Incomplete Hepatitis B Virus Viral Suppression Reply
    Boyd, Anders
    Peytavin, Gilles
    Lacombe, Karine
    HEPATOLOGY, 2016, 64 (03) : 1000 - 1001
  • [7] Tenofovir disoproxil fumarate (TDF) suppresses lamivudine-resistant HBV replication in patients co-infected with HIV/HBV
    Benhamou, Y
    Bochet, M
    Tubiana, R
    Thibault, V
    Suffisseau, L
    Sullivan, M
    Rooney, J
    Brosgart, C
    Bricaire, F
    Katlama, C
    Poynard, T
    JOURNAL OF HEPATOLOGY, 2002, 36 : 138 - 138
  • [8] Characteristics of HBeAg-positive patients chronically infected with hepatitis B virus (HBV) who achieved hbsag loss/seroconversion following tenofovir disoproxil fumarate (TDF) treatment
    Sievert, W.
    Gane, E. J.
    Strasser, S. I.
    George, J.
    Weilert, F.
    Desmond, P. A.
    Heathcote, E. J.
    Marcellin, P.
    Sorbel, J.
    Rousseau, F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A277 - A278
  • [9] Physician testing for HIV in patients treated with tenofovir disoproxil fumarate and lamivudine monotherapy for hepatitis B virus
    Lau, Jillian S. Y.
    Ratnam, Dilip
    Woolley, Ian
    SEXUAL HEALTH, 2018, 15 (01) : 89 - 90
  • [10] RENAL SAFETY AND ANTIVIRAL EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) MONOTHERAPY IN NUCLEOS(T)IDE ANALOGUE REFRACTORY PATIENTS WITH HEPATITIS B VIRUS (HBV) MONO-INFECTION
    van Boemmel, F.
    De Man, R. A.
    Ferenci, P.
    Reijnders, J. G.
    Bronowicki, J. -P.
    Wedemeyer, H.
    Brodzinski, A.
    Fueloep, B.
    Deterding, K.
    Erhardt, A.
    Hueppe, D.
    Bourliere, M.
    Sarrazin, C.
    Trojan, J.
    Buggisch, P. B.
    Petersen, J.
    Spengler, U.
    Pariente, A.
    Schuchmann, M.
    Wasmuth, H.
    Stein, K.
    Rutter, K.
    Feucht, H. -H.
    Wiedenmann, B.
    Berg, T.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S398 - S398